As the company’s goal To cut costs and splurge on spending amid uncertain macroeconomic conditions, Form Bio thinks it’s the perfect time to launch its platform. Software company developed at Colossal Biosciences – known for its goal of bringing extinct species like mammoth back to life – and currently stands out on its own.
Form Bio software was developed to deliver a suite of workflow solutions to computational biospace, using data and modeling to understand biological systems, and covers areas such as therapeutics. genetics and biotechnology.
The platform will use machine learning to help researchers and companies go from idea to scientific breakthrough faster by simplifying the data analysis processes in between and allowing users to choose from Existing workflow templates can be tailored to fit the specific needs of the company.
Profile form announced it spun out of Colossal Biosciences on September 27 with $30 million in funding led by JAZZ Venture Partners and Thomas Tull, both Colossal Biosciences investors.
Kent Wakeford, co-CEO of both Form Bio and Colossal, says that the idea for Form Bio began on day one of Colossal’s journey when they tried to get started and realized there was no single piece of software. as much as they can use.